Reversible vestibular dysfunction secondary to sotalol use.
Kapa
Suraj
S
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
Nagel
Jill J
JJ
Jahangir
Arshad
A
Asirvatham
Samuel J
SJ
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D013015:Sotalol / Q000009:adverse effects* / Q000627:therapeutic use; D015837:Vestibular Diseases / Q000139:chemically induced* / Q000517:prevention & control*
D000889:Anti-Arrhythmia Agents; D013015:Sotalol